CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 252 filers reported holding CONMED CORP in Q2 2021. The put-call ratio across all filers is 8.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,894,971 | -23.8% | 18,790 | +2.6% | 0.17% | -22.4% |
| Q2 2023 | $2,487,466 | +31.1% | 18,305 | +0.2% | 0.22% | +19.3% |
| Q1 2023 | $1,897,003 | +17.7% | 18,265 | +0.4% | 0.19% | +12.0% |
| Q4 2022 | $1,612,184 | +9.3% | 18,188 | -1.1% | 0.17% | +11.3% |
| Q3 2022 | $1,475,000 | -5.1% | 18,397 | +13.4% | 0.15% | -3.2% |
| Q2 2022 | $1,554,000 | -34.8% | 16,226 | +1.1% | 0.16% | -24.0% |
| Q1 2022 | $2,385,000 | -19.6% | 16,056 | -23.2% | 0.20% | -15.0% |
| Q4 2021 | $2,965,000 | +10.3% | 20,914 | +1.8% | 0.24% | 0.0% |
| Q3 2021 | $2,687,000 | -4.3% | 20,541 | +0.5% | 0.24% | -7.3% |
| Q2 2021 | $2,808,000 | +6.0% | 20,432 | +0.8% | 0.26% | 0.0% |
| Q1 2021 | $2,648,000 | +15.1% | 20,274 | -1.3% | 0.26% | +5.7% |
| Q4 2020 | $2,301,000 | +68.1% | 20,544 | +18.0% | 0.24% | +44.1% |
| Q3 2020 | $1,369,000 | -4.8% | 17,403 | -12.9% | 0.17% | -3.4% |
| Q2 2020 | $1,438,000 | – | 19,974 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 310,392 | $34,764,000 | 4.40% |
| Iron Triangle Partners LP | 148,317 | $16,612,000 | 2.15% |
| Ranger Investment Management | 294,664 | $33,002,000 | 1.74% |
| Penn Capital Management Company, LLC | 86,810 | $9,723,000 | 1.23% |
| EARNEST PARTNERS LLC | 1,575,336 | $176,438,000 | 1.22% |
| Champlain Investment Partners, LLC | 1,692,014 | $189,506,000 | 1.09% |
| MOODY ALDRICH PARTNERS LLC | 59,005 | $6,609,000 | 1.07% |
| Hood River Capital Management LLC | 232,412 | $26,030,000 | 0.86% |
| OAK RIDGE INVESTMENTS LLC | 80,775 | $9,047,000 | 0.80% |
| Huber Capital Management LLC | 18,620 | $2,085,000 | 0.68% |